Nick Pannunzio

Prof. Nick Pannunzio

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2024 in Science Advances
Verified
Journal Article
Open access
RFRachel C. Fellows
Rachel C. Fellows
SCSung Kook Chun
Sung Kook Chun
NLNatalie Larson
Natalie Larson
BFBridget M. Fortin
Bridget M. Fortin
AMAlisa L. Mahieu
Alisa L. Mahieu
SMSelma Masri
Selma Masri
Diet is a robust entrainment cue that regulates diurnal rhythms of the gut microbiome. We and others have shown that disruption of the circadian clock drives the progression of colorectal cancer (CRC). While certain bacterial species have been suggested to play driver roles in CRC, it is unknown whether the intestinal clock impinges on the microbiome to accelerate CRC pathogenesis. To address this, genetic disruption of the circadian clock, in an Apc- driven mouse model of CRC, was used to define the impact on the gut microbiome. When clock disruption is combined with CRC, metagenomic sequencing identified dysregulation of many bacterial genera including Bacteroides , Helicobacter , and Megasphaera. We identify functional changes to microbial pathways including dysregulated nucleic acid, amino acid, and carbohydrate metabolism, as well as disruption of intestinal barrier function. Our findings suggest that clock disruption impinges on microbiota composition and intestinal permeability that may contribute to CRC pathogenesis.

26 May 2025 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
BFBridget M. Fortin
Bridget M. Fortin
AMAlisa L. Mahieu
Alisa L. Mahieu
RFRachel C. Fellows
Rachel C. Fellows
YKYi Kang
Yi Kang
ALAmber N. Lewis
Amber N. Lewis
SMSelma Masri
Selma Masri

31 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JKJessica L. Kelliher
Jessica L. Kelliher
MFMelissa L. Folkerts
Melissa L. Folkerts
KSKaiyuan V. Shen
Kaiyuan V. Shen
WSWan Song
Wan Song
KTKyle Tengler
Kyle Tengler
JLJustin Leung
Justin Leung
The master DNA damage repair histone protein, H2AX, is essential for orchestrating the recruitment of downstream mediator and effector proteins at damaged chromatin. The phosphorylation of H2AX at S139, γH2AX, is well-studied for its DNA repair function. However, the extended C-terminal tail is not characterized. Here, we define the minimal motif on H2AX for the canonical function in activating the MDC1-RNF8-RNF168 phosphorylation-ubiquitination pathway that is important for recruiting repair proteins, such as 53BP1 and BRCA1. Interestingly, H2AX recruits 53BP1 independently from the MDC1-RNF8-RNF168 pathway through its evolved C-terminal linker region with S139 phosphorylation. Mechanistically, 53BP1 recruitment to damaged chromatin is mediated by the interaction between the H2AX C-terminal tail and the 53BP1 Oligomerization-Tudor domains. Moreover, γH2AX-linker mediated 53BP1 recruitment leads to camptothecin resistance in H2AX knockout cells. Overall, our study uncovers an evolved mechanism within the H2AX C-terminal tail for regulating DNA repair proteins at damaged chromatin.

16 May 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
BFBridget M. Fortin
Bridget M. Fortin
AMAlisa L. Mahieu
Alisa L. Mahieu
RFRachel C. Fellows
Rachel C. Fellows
NPNick Pannunzio
Nick Pannunzio
SMSelma Masri
Selma Masri
In modern society, there is a growing population affected by circadian clock disruption through night shift work, artificial light-at-night exposure, and erratic eating patterns. Concurrently, the rate of cancer incidence in individuals under the age of 50 is increasing at an alarming rate, and though the precise risk factors remain undefined, the potential links between circadian clock deregulation and young-onset cancers is compelling. To explore the complex biological functions of the clock, this review will first provide a framework for the mammalian circadian clock in regulating critical cellular processes including cell cycle control, DNA damage response, DNA repair, and immunity under conditions of physiological homeostasis. Additionally, this review will deconvolute the role of the circadian clock in cancer, citing divergent evidence suggesting tissue-specific roles of the biological pacemaker in cancer types such as breast, lung, colorectal, and hepatocellular carcinoma. Recent evidence has emerged regarding the role of the clock in the intestinal epithelium, as well as new insights into how genetic and environmental disruption of the clock is linked with colorectal cancer, and the molecular underpinnings of these findings will be discussed. To place these findings within a context and framework that can be applied towards human health, a focus on how the circadian clock can be leveraged for cancer prevention and chronomedicine-based therapies will be outlined.

6 November 2023 in European Journal of Haematology
Verified
Journal Article
Open access
BLBenjamin J. Lee
Benjamin J. Lee
SGShawn Patrick Griffin
Shawn Patrick Griffin
JDJean Doh
Jean Doh
ACAlexandre Chan
Alexandre Chan
SCStefan Ciurea
Stefan Ciurea
PKPiyanuch Kongtim
Piyanuch Kongtim
Objective: There are significant disparities in outcomes among Hispanic patients with acute lymphoblastic leukemia (ALL). Recent studies have demonstrated favorable outcomes of pegaspargase‐containing ALL regimens (PEG‐CAR) in young adults however, outcomes in Hispanic ethnicity continue to be underreported.Methods: We evaluated outcomes of newly diagnosed, adult B‐cell ALL Hispanic and non‐Hispanic patients consecutively treated with a PEG‐CAR or HyperCVAD between January 2011 and November 2022. The primary endpoint was event‐free survival (EFS) while secondary endpoints included cumulative incidence of relapse and overall survival (OS).Results: Among 105 included patients, 48 (45.7%) were treated with a PEG‐CAR and 57 (54.3%) with HyperCVAD. Median age was 38 years (range, 18–75 years), 61% were Hispanic, and 35.2% had poor‐genetic risk. Hispanic patients demonstrated significantly worse 5‐year EFS with a PEG‐CAR compared to that seen with HyperCVAD (HR, 2.58; 95% CI, 1.32–5.04; p = .006) whereas non‐Hispanic patients had better outcomes with PIR (52.4% vs. 42.0%). Hispanic ethnicity (p = .015) and male sex (p = .019) were independent predictors for poor OS.Conclusions: Hispanic patients with B‐cell ALL had worse EFS with a PEG‐CAR as compared with HyperCVAD. Future studies will aim to confirm these findings and establish a tailored treatment approach for this high‐risk population.

31 January 2022 in Trends in Cancer
Verified
Journal Article
Closed access
PDF file
JSJason N. Sterrenberg
Jason N. Sterrenberg
MFMelissa L. Folkerts
Melissa L. Folkerts
VRValeria Rangel
Valeria Rangel
SLSarah Eugenie Lee
Sarah Eugenie Lee
NPNick Pannunzio
Nick Pannunzio